Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Clinical Trials Manual This manual is based on Health Canada's Guidance for Clinical Trial Sponsors: Clinical Trial Applications and other applicable guidance documents. It is designed to provide tools and relevant links in order to facilitate the successful filing of a Clinical…
Guidance on expanded access clinical trials: Overview Overview Information for potential participants Information for sponsors and health care providers Contact information Glossary Download in PDF format (808 KB, 31 pages) Organization: Health Canada Published: 2025-09-29 Cat.:…
Chemical Entity Products/Quality Guidance Document: Quality (Chemistry and Manufacturing): New Drug Submissions (NDSs) and Abbreviated New Drug Submissions (ANDSs) [2024-12-18] Guidance Document: Addendum - Quality (Chemistry and Manufacturing) Guidance: Questions and Answers…
Guidance Document: Use of a Foreign-sourced Reference Product as a Canadian Reference Product Download the alternative format (PDF format, 264 KB, 14 pages) Foreword Guidance documents are meant to provide assistance to industry and health care professionals on how to comply with…
Guidance for industry on safety monitoring and reporting requirements for marketed biocides: Overview Overview Safety monitoring Serious incident reporting Issue-related reports Information retention requirements Definitions Download in PDF format (593 KB, 28 pages) Organization:…
Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format (PDF Version - 91 K) Contact: Bureau of Pharmaceutical Sciences (BPS) Enquiries Draft Guidance For Industry Preparation of Comparative Bioavailability…
Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry (PDF Version - 118 K) Contact: Bureau of Cardiology, Allergy and Neurological Sciences (BCANS) September 19, 2011 Notice Our…
Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects (PDF Version - 319 K) Date Adopted: 2012/12/08 Revised Date: 2018/06/08 Effective Date: 2018/09/01 (for submissions filed on or after September 1, 2018) Please refer to the Notice to…
Comparative Pharmacokinetic Studies for Orally Inhaled Products: Guidance Document ( PDF version , 250 KB) Date adopted: December 21, 2020 Date posted: December 21, 2020 Effective date: December 21, 2020 On this page Introduction Policy objectives Policy statement Scope and…
Notice: Guidance Document - Data Requirements for Safety and Effectiveness of Subsequent Entry Inhaled Corticosteroid Products Used for the Treatment of Asthma October 31, 2018 Our file number: 18-111871-354 Health Canada is pleased to announce the release of the Guidance…
Page 4250 sur 6399Affichage de 42491 à 42500 sur 63986
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
